Login to Your Account

Next: NSCLC Combo Trial

OSI's Phase III Adrenal-Tumor Drug Could Be Tarceva Add-on

By Jennifer Boggs

Tuesday, September 8, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription